Board Change • May 21
High number of new directors CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. Announcement • Apr 27
IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion. IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion on April 27, 2026. A cash consideration valued at AUD 4.75 per share will be paid by IFM Global Infrastructure Fund and IFM Investors Pty Ltd. The Offer Price will be increased to the Maximum Consideration of AUD 5.10 per Security if Bidder's Relevant Interest in Atlas Arteria Securities is 45% or more prior to the close of the Offer. IFM GIF has access to existing cash balances, funding commitments from its investors and third party debt on an unconditional basis which in aggregate exceed the Offer Amount and are sufficient to support the Funding Commitments. Under the Funding Commitments, IFM GIF and IFM Finance will make available cash amounts in aggregate of not less than the Offer Amount for the purpose of funding the aggregate consideration for the acquisition of the Securities to which the Offer relates. The Funding Commitments are not subject to any conditions. Bidder may also proceed to compulsory acquisition of the Performance Rights which have not been exercised and that have not lapsed, or alternatively pursue other arrangements in relation to those Performance Rights. Atlas Arteria Limited advises that shareholders take no action in relation to the Offer.
The transaction is subject to subject to antitrust regulations, approval by regulatory board / committee and third party approval needed. The Boards of Atlas Arteria will establish an Independent Board Committee to consider the Offer.
Allens acted as legal advisor for IFM Investors Pty Ltd. Carey Olsen LLP acted as legal advisor for IFM Investors Pty Ltd. Jarden Australia Pty Limited acted as financial advisor for IFM Investors Pty Ltd. MUFG Corporate Markets Limited acted as transfer agent/registrar for IFM Investors Pty Ltd. Flagstaff Partners Pty Ltd and UBS AG act as financial advisor and Mallesons Stephen Jaques act as legal advisor for Atlas Arteria Limited. Announcement • Mar 17
Atlas Arteria Limited to Report First Half, 2026 Results on Aug 26, 2026 Atlas Arteria Limited announced that they will report first half, 2026 results on Aug 26, 2026 Announcement • Mar 16
Atlas Arteria Limited, Annual General Meeting, May 13, 2026 Atlas Arteria Limited, Annual General Meeting, May 13, 2026. Board Change • Dec 30
High number of new directors There are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • Nov 10
Atlas Arteria Limited to Report Fiscal Year 2025 Results on Feb 26, 2026 Atlas Arteria Limited announced that they will report fiscal year 2025 results on Feb 26, 2026 Announcement • Jul 18
Atlas Arteria Limited Announces Virginia Supreme Court Decision Affirms SCC Rate Case Appeal Atlas Arteria noted the decision made by the Supreme Court of Virginia (SCV) on 17 July 2025 affirming the 2024 State Corporation Commission's (SCC) decision denying Toll Road Investors Partnership II (TRIP II)'s latest toll rate application for the Dulles Greenway. TRIP II's pending federal case, which was stayed in anticipation of the SCV appeal decision, will now proceed. The federal complaint alleges constitutional violations distinct from those decided by the SCV and seeks compensatory, declarative, injunctive, and other relief, unavailable to TRIP II in the SCV appeal. TRIP II continues to engage with the SCC working group and anticipates submitting a new rate application this year. Announcement • Mar 20
Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025 Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2024, consistent with guidance provided in full year results announcement on 27 February 2025. Stapled securities trade ex-entitlement date is 25 March 2025. Record date is 26 March 2025. Estimated payment date is 4 April 2025. Announcement • Mar 11
Atlas Arteria Limited, Annual General Meeting, May 15, 2025 Atlas Arteria Limited, Annual General Meeting, May 15, 2025. Declared Dividend • Sep 22
First half dividend of AU$0.20 announced Shareholders will receive a dividend of AU$0.20. Ex-date: 24th September 2024 Payment date: 7th October 2024 Dividend yield will be 11%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (194% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 116% to bring the payout ratio under control. EPS is expected to grow by 68% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio. Announcement • Sep 19
Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024 Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2024, consistent with guidance provided in half year results announcement on 29 August 2024. Stapled securities trade ex-entitlement: 24 September 2024. Record date: 25 September 2024. Estimated payment date: 7 October 2024. The distribution will be paid by Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX) and will be an unfranked distribution. Board Change • Sep 10
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non-Executive Director Danny Elia was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 30
First half 2024 earnings released: EPS: AU$0.099 (vs AU$0.12 in 1H 2023) First half 2024 results: EPS: AU$0.099 (down from AU$0.12 in 1H 2023). Revenue: AU$69.6m (up 9.6% from 1H 2023). Net income: AU$144.3m (down 14% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Infrastructure industry in Europe. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Declared Dividend • Mar 24
Final dividend of AU$0.20 announced Shareholders will receive a dividend of AU$0.20. Ex-date: 26th March 2024 Payment date: 8th April 2024 Dividend yield will be 10%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (132% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 20% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 47% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Announcement • Mar 21
Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024 Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2023, consistent with guidance provided in full year results announcement on 29 February 2024. Stapled securities trade ex-entitlement is on 26 March 2024. Record date is on 27 March 2024 and estimated payment date is on 8 April 2024. Announcement • Mar 14
Atlas Arteria Limited, Annual General Meeting, May 16, 2024 Atlas Arteria Limited, Annual General Meeting, May 16, 2024, at 10:01 AUS Eastern Standard Time. Reported Earnings • Feb 29
Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022) Full year 2023 results: EPS: AU$0.22. Revenue: AU$134.0m (down 4.5% from FY 2022). Net income: AU$323.5m (up 21% from FY 2022). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Infrastructure industry in Europe. Announcement • Oct 16
Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director Atlas Arteria announced the appointment of Ms Laura Hendricks to the Board of Atlas Arteria Limited (ATLAX) as an Independent Non-executive Director effective immediately. Ms Hendricks is currently Chief Executive Officer of Transdev U.S., the largest operator and integrator of multiple modes of transportation in the United States. Laura has worked in a number of roles in the transportation industry across the US for more than 20 years and also has international experience working with shareholders in Europe, specifically in France and Germany. Ms Hendricks is also currently Chair of the North American Transit Alliance, an organization that advocates for the essential role that private contractors play in public transit. Prior to joining Transdev U.S., Ms Hendricks was President and/or CEO of several companies including Paint Drop by Valspar, Coach America and Merry Maids. Ms Hendricks also spent several years in executive leadership roles at Cintas and Fed Ex. Ms Hendricks is an accomplished senior executive with broad leadership experience in operations, including full P&L responsibility, business development, supply chain management, financial oversight, M&A, culture-building and change management. In her various roles, Ms Hendricks has also gained significant government relations experience in the United States, including working with public authorities and regulators. Ms Hendricks graduated from Xavier University with a Bachelor of Liberal Arts degree. Announcement • Sep 22
Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023 Atlas Arteria announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2023. Stapled securities trade ex-entitlement is 25 September 2023, Record date is 26 September 2023 and Estimated payment date is 5 October 2023. Announcement • Aug 31
Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023 Atlas Arteria Limited reaffirmed distribution guidance of 20.0 cents per security for first half of 2023, and 20.0 cents per security for second half of 2023. Announcement • Jun 14
Atlas Arteria Limited to Report Fiscal Year 2023 Results on Feb 29, 2024 Atlas Arteria Limited announced that they will report fiscal year 2023 results on Feb 29, 2024 Announcement • Jun 07
Atlas Arteria Limited Appoints Ken Daley as Director Atlas Arteria Limited appointed Ken Daley as Director. Date of appointment 30 May 2023. Announcement • Jun 01
Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023 Atlas Arteria Limited announced that Ms Caroline Foulger will retire as a Director of Atlas Arteria International Limited with effect from 1 July 2023. 
